Loop Capital initiated coverage on atai Life Sciences N.V. with a new price target
$ATAI
Biotechnology: Pharmaceutical Preparations
Health Care
Loop Capital initiated coverage of atai Life Sciences N.V. with a rating of Buy and set a new price target of $18.00